Abstract
Contrast-induced nephropathy (CIN) is associated with prolonged hospitalization and adverse clinical outcomes. Useful predictors of CIN are necessary to minimize the risk of developing CIN. The purpose of this study was to identify the useful predictors of CIN. We prospectively measured serum cystatin C (CysC) and β2-microglobulin (β2-MG), and urinary liver-type fatty acid-binding protein (L-FABP), β2-MG and N-acetyl-β-d-glucosaminidase (NAG) before and 1 day after percutaneous coronary intervention (PCI) in 96 patients with stable angina who underwent elective PCI. The frequency of CIN was 5% (5/96). Baseline levels of serum β2-MG (4.2 ± 2.6 vs. 2.2 ± 1.0 mg/L, p = 0.0007) and CysC (1.51 ± 0.52 vs. 1.11 ± 0.34 mg/L, p = 0.013) were significantly higher in the CIN group. Urinary β2-MG, NAG, and L-FABP levels became significantly elevated after PCI. Of these, the mean change of urinary L-FABP was significantly higher in the CIN group (25.2 ± 31.5 vs. 8.9 ± 16.3 ng/mL, p = 0.044). Univariate linear regression analyses showed that the change of urinary L-FABP correlated positively with the volume of contrast medium (r = 0.460, p < 0.0001). Receiver-operating characteristic analysis showed that baseline serum β2-MG exhibited 75% sensitivity and 80% specificity at a cut-off point of >2.8 mg/L, and baseline serum CysC exhibited 75% sensitivity and 73% at a cut-off point of >1.26 mg/L for predicting CIN. In conclusion, baseline serum β2-MG and CysC were useful predictors of CIN. The change of urinary L-FABP serves as an indicator of renal injury due to contrast medium and as an adjunct predictor of CIN.
Similar content being viewed by others
References
McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention: incidence, risk factors and relationship to mortality. Am J Med. 1997;103:368–75.
Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–64.
Tepel M, Zidek W. N-Acetylcysteine in nephrology: contrast nephropathy and beyond. Curr Opin Nephrol Hypertens. 2004;13:649–54.
Brezis M, Rosen S. Hypoxia of the renal medulla—its implications for disease. N Engl J Med. 1995;332:647–55.
Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv. 2001;52:409–16.
Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992;38:1933–53.
Haycock GB. Creatinine, body size and renal function. Pediatr Nephrol. 1989;3:22–4.
Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36:29–34.
Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352:2049–60.
Hamilton JA, Era S, Bhamidipati SP, Reed RG. Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin. Proc Natl Acad Sci USA. 1991;88:2051–4.
Veerkamp JH, Peeters RA, Maatman RG. Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim Biophys Acta. 1991;1081:1–24.
Kamijo A, Sugaya T, Hikawa A, Okada M, Okumura F, Yamanouchi M, et al. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol. 2004;165:1243–55.
Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hikawa A, Hirano N, et al. Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med. 2004;143:23–30.
MacNeill BD, Harding SA, Bazari H, Patton KK, Colon-Hernadez P, DeJoseph D, et al. Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography. Catheter Cardiovasc Interv. 2003;60:458–61.
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.
Hayashi T, Nitta K, Hatano M, Nakauchi M, Nihei H. The serum cystatin C concentration measured by particle-enhanced immunonephelometry is well correlated with insulin clearance in patients with various types of glomerulonephritis. Nephron. 1999;82:90–2.
Nozue T, Michishita I, Iwaki T, Mizuguchi I, Miura M. Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention. J Cardiol. 2009;54:214–20.
Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40:221–6.
Kato K, Sato N, Yamamoto T, Iwasaki YK, Tanaka K, Mizuno K. Valuable markers for contrast-induced nephropathy in patients undergoing cardiac catheterization. Circ J. 2008;72:1499–505.
Artunc FH, Fischer IU, Risler T, Erley CM. Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization. Int J Cardiol. 2005;102:173–8.
Nakamura T, Sugaya T, Node K, Ueda Y, Koide H. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis. 2006;47:439–44.
Nakamura T, Sugaya T, Koide H. Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure. Diabetologia. 2007;50:490–2.
Nakamura T, Sugaya T, Kawagoe Y, Suzuki T, Inoue T, Node K. Effect of pitavastatin on urinary liver-type fatty-acid-binding protein in patients with nondiabetic mild chronic kidney disease. Am J Nephron. 2006;26:82–6.
Sheridan AM, Schwartz JH, Kroshian VM, Tercyak AM, Laraia J, Masino S, et al. Renal mouse proximal tubular cells are more susceptible than MDCK cells to chemical anoxia. Am J Physiol. 1993;265:F342–50.
Kees-Folts D, Sadow JL, Schreiner GF. Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int. 1994;45:1697–709.
Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hase H, Kaneko T, et al. Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int. 2002;62:1628–37.
Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, et al. CIN Consensus Working Panel pathophysiology of contrast-induced nephropathy. Am J Cardiol. 2006;98:14K–20K.
Kamijo-Ikemori A, Sugaya T, Kimura K. Urinary fatty acid binding protein in renal disease. Clin Chim Acta. 2006;374:1–7.
Solomon R, Werner C, Mann D, D’Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416–20.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nozue, T., Michishita, I. & Mizuguchi, I. Predictive value of serum cystatin C, β2-microglobulin, and urinary liver-type fatty acid-binding protein on the development of contrast-induced nephropathy. Cardiovasc Interv and Ther 25, 85–90 (2010). https://doi.org/10.1007/s12928-010-0014-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12928-010-0014-3